 OLAPARIB TREATMENT IN RELAPSED GERMLINE BREAST CANCER SUSCEPTIBILITY GENE BRCA MUTATED OVARIAN CANCER PATIENTS WHO HAVE PROGRESSED AT LEAST 6 MONTHS AFTER LAST PLATINUM TREATMENT AND HAVE RECEIVED AT LEAST 2 PRIOR PLATINUM TREATMENTS: 